|
Volumn 7, Issue 4, 2005, Pages 485-
|
What's new in nicotine & tobacco research?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
CLONIDINE;
COTININE;
DRUG METABOLITE;
LEAD;
MENTHOL;
NICOTINE;
NON PRESCRIPTION DRUG;
NORTRIPTYLINE;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COPING BEHAVIOR;
DECISION MAKING;
DEPRESSION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
ENVIRONMENTAL EXPOSURE;
EXPECTATION;
HEALTH HAZARD;
HEALTH PROGRAM;
HEALTH PROMOTION;
HEALTH SURVEY;
HIGH RISK PATIENT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEAD POISONING;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
NICOTINE REPLACEMENT THERAPY;
PACKAGING;
PASSIVE SMOKING;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PREDICTION;
PRESCRIPTION;
PRIORITY JOURNAL;
QUESTIONNAIRE;
RACE DIFFERENCE;
RELAPSE;
RISK ASSESSMENT;
RISK FACTOR;
RISK REDUCTION;
SEX DIFFERENCE;
SMOKING CESSATION;
SOCIAL BELIEF;
SOCIAL CONTROL;
SOCIOECONOMICS;
TOBACCO;
TOBACCO DEPENDENCE;
TOBACCO INDUSTRY;
WITHDRAWAL SYNDROME;
|
EID: 27744580766
PISSN: 14622203
EISSN: 1469994X
Source Type: Journal
DOI: 10.1080/14622200500186577 Document Type: Article |
Times cited : (1)
|
References (0)
|